Moderna Q1 revenue $6.1B, net income $3.7B; reiterates $21B 2022 APAs

Moderna, Inc.

2022-Q1 EPS reported $8.58 revenue$6,066,000,000

GAAP diluted EPS of $8.58 vs $2.84 YoY; revenue tripled to $6.1B from $1.9B.
Cost of sales 17% of product sales; R&D $554M, SG&A $268M.
Cash, equivalents, and investments $19.3B at quarter end; operating cash flow $2.8B.
Four programs in Phase 3 in Q2: Omicron bivalent COVID booster, flu, RSV, CMV.
CFO David Meline retiring; Jorge Gomez appointed CFO effective May 9, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.